Parkman Healthcare Partners LLC Buys New Holdings in Oscar Health, Inc. (NYSE:OSCR)

Parkman Healthcare Partners LLC acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 250,000 shares of the company's stock, valued at approximately $5,302,000. Parkman Healthcare Partners LLC owned 0.10% of Oscar Health as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in OSCR. Janney Montgomery Scott LLC bought a new stake in shares of Oscar Health in the 3rd quarter worth about $988,000. Versor Investments LP bought a new stake in Oscar Health in the third quarter valued at about $787,000. Algert Global LLC increased its holdings in shares of Oscar Health by 63.3% in the 3rd quarter. Algert Global LLC now owns 369,685 shares of the company's stock valued at $7,841,000 after acquiring an additional 143,346 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of Oscar Health in the 3rd quarter valued at approximately $1,282,000. Finally, Assenagon Asset Management S.A. increased its holdings in shares of Oscar Health by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company's stock valued at $32,368,000 after acquiring an additional 507,009 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Insider Activity at Oscar Health

In related news, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the firm's stock in a transaction that occurred on Tuesday, November 12th. The stock was acquired at an average cost of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the acquisition, the director now owns 5,452,081 shares in the company, valued at $74,584,468.08. This trade represents a 8.36 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Steven Wolin sold 19,580 shares of Oscar Health stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $354,006.40. Following the sale, the chief operating officer now directly owns 102,598 shares of the company's stock, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 150,360 shares worth $2,645,074. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Price Performance

NYSE:OSCR traded down $1.03 during midday trading on Wednesday, hitting $16.96. 4,500,286 shares of the stock were exchanged, compared to its average volume of 3,437,271. The business has a 50-day moving average price of $17.18 and a two-hundred day moving average price of $17.94. Oscar Health, Inc. has a one year low of $7.50 and a one year high of $23.79. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of -282.95 and a beta of 1.63. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business's revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the business posted ($0.29) EPS. Sell-side analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on OSCR. Piper Sandler reiterated an "overweight" rating and set a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective for the company. Finally, Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $22.93.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.